Page last updated: 2024-08-24

goralatide and Cardiac Remodeling, Ventricular

goralatide has been researched along with Cardiac Remodeling, Ventricular in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (60.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Carretero, OA; Dai, X; González, GE; Leung, P; Liao, TD; Liu, Y; Nakagawa, P; Rhaleb, NE; Yang, XP1
André, S; Carretero, OA; D'Ambrosio, M; Gabius, HJ; Liao, TD; Liu, YH; Peng, H; Rhaleb, NE; Sharma, U1
Merali, S; Sherwi, N; Wong, K1
Caers, J; Vanderkerken, K1
Cavasin, MA1

Reviews

2 review(s) available for goralatide and Cardiac Remodeling, Ventricular

ArticleYear
Personalizing biomarker strategies in heart failure with galectin-3.
    Future cardiology, 2012, Volume: 8, Issue:6

    Topics: Biomarkers; Fibrosis; Galectin 3; Heart Failure; Humans; Oligopeptides; Prognosis; Translational Research, Biomedical; Ventricular Remodeling

2012
Therapeutic potential of thymosin-beta4 and its derivative N-acetyl-seryl-aspartyl-lysyl-proline (Ac-SDKP) in cardiac healing after infarction.
    American journal of cardiovascular drugs : drugs, devices, and other interventions, 2006, Volume: 6, Issue:5

    Topics: Animals; Heart; Humans; Models, Biological; Myocardial Infarction; Myocardium; Oligopeptides; Thymosin; Ventricular Remodeling

2006

Other Studies

3 other study(ies) available for goralatide and Cardiac Remodeling, Ventricular

ArticleYear
N-acetyl-seryl-aspartyl-lysyl-proline reduces cardiac collagen cross-linking and inflammation in angiotensin II-induced hypertensive rats.
    Clinical science (London, England : 1979), 2014, Jan-01, Volume: 126, Issue:1

    Topics: Amino Acid Oxidoreductases; Angiotensin II; Animals; Body Weight; Cardiomegaly; CD4-Positive T-Lymphocytes; Collagen; Extracellular Matrix; Hypertension; Inflammation; Lung; Male; NF-kappa B; Oligopeptides; Organ Size; Protein-Lysine 6-Oxidase; Rats; Rats, Inbred Lew; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Ventricular Function, Left; Ventricular Remodeling

2014
N-acetyl-seryl-aspartyl-lysyl-proline prevents cardiac remodeling and dysfunction induced by galectin-3, a mammalian adhesion/growth-regulatory lectin.
    American journal of physiology. Heart and circulatory physiology, 2009, Volume: 296, Issue:2

    Topics: Animals; Anti-Inflammatory Agents; Blood Pressure; Body Weight; Cardiac Output; Cardiomegaly; Cardiotonic Agents; Collagen; Disease Models, Animal; Echocardiography, Doppler; Fibrosis; Galectin 3; Heart Rate; Hemodynamics; Inflammation; Infusions, Parenteral; Isoproterenol; Macrophages; Male; Mast Cells; Myocardial Contraction; Myocardium; Oligopeptides; Phosphorylation; Rats; Rats, Sprague-Dawley; Signal Transduction; Smad3 Protein; Stroke Volume; Time Factors; Transforming Growth Factor beta; Ventricular Function, Left; Ventricular Remodeling

2009
Ac-SDKP: linking cardiac remodeling to hematological malignancies.
    Leukemia & lymphoma, 2006, Volume: 47, Issue:9

    Topics: Animals; Growth Inhibitors; Hematologic Neoplasms; Humans; Neovascularization, Pathologic; Oligopeptides; Ventricular Remodeling

2006